FDA Cross-Center Collaboration Act of 2016
Sponsored By: Representative Upton, Fred [R-MI-6]
Unknown
Summary
FDA Cross-Center Collaboration Act of 2016 This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to establish one or more Intercenter Institutes. Each institute must coordinate activities applicable to a major disease area among the FDA centers that review products. Activities may include coordinating staff with relevant expertise, streamlining product review, and enhancing interactions with patients, sponsors, and the biomedical community.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Upton, Fred [R-MI-6]
MI • R
Cosponsors
Rep. Pallone, Frank [D-NJ-6]
NJ • D
Sponsored 6/8/2016
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov